Anti-CD16a NK Cell Engager Platform

About AvantGen

AvantGen is a private, platform-focused biotech company that provides antibody discovery and optimization services and develops its own therapeutic assets. The company's core strength is its proprietary yeast display platform and its fully human Germliner™ antibody library, which it uses to generate high-quality leads for partners and for internal programs, including a CD16a NK cell engager platform. AvantGen has demonstrated success through multiple partnerships, milestone payments from collaborators like Kite Pharma, and NIH grants, positioning it as a growing player in the antibody therapeutics space. Its business model blends fee-for-service work, collaborative partnerships, and out-licensing of its antibody assets.

Therapeutic Areas